Pancreatic neuroendocrine tumors are also associated with C-MYC overexpression which also promotes vascular endothelial growth factor C (VEGFC) expression the development of lymphatic endothelial cells (Chang et al., 2021). This evidence concerns the gene VEGFC and pancreatic neuroendocrine tumor.